Watchlist Price Alert

Kura Oncology Inc. (KURA)

NASDAQ: KURA · Real-Time Price · USD

6.48

0.04 (0.62%)

At close: Jun 16, 2025, 3:59 PM

6.51

0.46%

After-hours: Jun 16, 2025, 05:39 PM EDT

0.62% (1D)

Bid	6.48
Market Cap	561M
Revenue (ttm)	67.99M
Net Income (ttm)	-181.89M
EPS (ttm)	-2.09
PE Ratio (ttm)	-3.1
Forward PE	-3.45
Analyst	Buy

Ask	7.45
Volume	928,939
Avg. Volume (20D)	1,284,174
Open	6.49
Previous Close	6.44
Day's Range	6.33 - 6.58
52-Week Range	5.41 - 23.48
Beta	0.40

About KURA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol KURA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

+10.72%

Kura Oncology shares are trading higher after the ... Unlock content with Pro Subscription

4 months ago

-2.54%

Kura Oncology shares are trading lower. The company announced topline results from KOMET-001.

News

4 days ago · zacks.com

Is the Options Market Predicting a Spike in Kura Oncology Stock?

Investors need to pay close attention to KURA stock based on the movements in the options market lately.

1 week ago · zacks.com

KURA Stock Rises More Than 15% This Past Week: Here's Why

Kura Oncology shares rise this week after the FDA accepts its NDA for ziftomenib, a potential first-in-class treatment for NPM1-mutant AML.

1 month ago · seekingalpha.com

Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Troy Wilson – President and Chief Executive Officer Mollie Leoni – Chief Medical Officer...

1 month ago · zacks.com

Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.59 per share a year ago.